logo
[breadcrumb_custom]

Tag: NXTC Shares

Finance

Behind Nextcure Inc’s 52-Week Range: Uncovering Opportunities for Investors

Nextcure Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $2.35 on 04/02/24, while the lowest price for the same duration was marked at $0.98 on 10/25/23. 52-week price history of NXTC Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Nextcure Inc’s current trading price is 5.96% away from its 52-week high, while its distance from the 52-week low is 154.08%. The stock’s price range during this period has spanned from $0.98 to $2.35. In the Healthcare sector, the Nextcure Inc’s

Industry

NXTC: Riding the Market Waves of Growth and Decline in 2023

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 95.61%.However, over the last six months, we can see a weaker performance of 70.23%. Over the last 30 days, the price of NXTC has fallen by 39.37%. And in the last five days, it has surged by 32.74%. Nextcure Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $2.09 on 03/28/24 and the lowest value was

AMZN
News

Nextcure Inc (NXTC) Stock: A Year of Market Movement, Down and Up

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Nextcure Inc’s current trading price is -4.78% away from its 52-week high, while its distance from the 52-week low is 103.06%. The stock’s price range over this period has fluctuated between $0.98 and $2.09. The company, operating within the financial sector, had a trading volume of approximately 0.38 million for the day, which was noticeably higher than the average daily share volume of 0.23 million over the last 3 months. Nextcure Inc ‘s stock market performance has

Finance

Nextcure Inc (NXTC) Stock: A Year of Stock Market Ups and Downs

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Nextcure Inc’s current trading price is -9.09% away from its 52-week high, while its distance from the 52-week low is 93.88%. The stock’s price range for this time frame has been between $0.98 and $2.09. The trading volume of the company’s shares in the Healthcare reached around 1.02 million for the day, which was evidently higher than the average daily volume of 0.21 million over the last three months. In terms of market performance, Nextcure Inc had a somewhat

ZM Stock
Industry

Nextcure Inc (NXTC) Stock: From Low to High in 52 Weeks

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Nextcure Inc’s current trading price is -19.14% away from its 52-week high, while its distance from the 52-week low is 72.45%. The stock’s price range for this period has been between $0.98 and $2.09 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.07 million for the day, a number notably higher than the average daily volume of 0.18 million over the last three months. The market performance of Nextcure Inc’s stock has

Stock

Behind Nextcure Inc’s 52-Week Range: Uncovering Opportunities for Investors

Nextcure Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $2.09 on 03/04/24, while the lowest price for the same duration was marked at $0.98 on 10/25/23. 52-week price history of NXTC Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Nextcure Inc’s current trading price is -19.38% away from its 52-week high, while its distance from the 52-week low is 71.94%. The stock’s price range during this period has spanned from $0.98 to $2.09. In the Healthcare sector, the Nextcure Inc’s